Published Date: 20-11-2020
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report Europe Pneumonia Testing Market, published by KBV research, the Europe Pneumonia Testing Market would witness market growth of 8.5% CAGR during the forecast period (2020-2026).
The Germany market dominated the Europe Pneumonia Testing Hospitals Market by Country 2019, growing at a CAGR of 8.2 % during the forecast period. The UK market is experiencing a CAGR of 7.9% during (2020 - 2026). Additionally, The France market is poised to grow at a CAGR of 10.4% during (2020 - 2026).
The Analyzers market dominated the Russia Pneumonia Testing Market by Type 2019, growing at a CAGR of 8 % during the forecast period. The Consumables market is expected to witness a CAGR of 10.8% during (2020 - 2026).
The Enzyme-Linked Immunosorbent Assay (ELISA) market dominated the Italy Pneumonia Testing Market by Technology 2019, thereby, achieving a market value of $8.5 million by 2026. The Immunofluorescence market is estimated to grow at a CAGR of 9.9% during (2020 - 2026). The Western Blot market is witnessing a CAGR of 7.8% during (2020 - 2026). Additionally, The Immunohistochemistry (IHC) market would showcase highest CAGR of 11.7% during (2020 - 2026).
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Abbott Laboratories, Becton, Dickinson and Company, bioMérieux, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Hologic, Inc., Meridian Bioscience Inc., Quest Diagnostics Incorporated, Quidel Corporation and Thermo Fisher Scientific.
By End User
Unique Offerings from KBV Research